Literature DB >> 21030995

Velaglucerase alfa.

Johannes M F G Aerts, Uma Yasothan, Peter Kirkpatrick.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21030995     DOI： 10.1038/nrd3311

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  17 in total

1.  Short-term withdrawal from imiglucerase: what can we learn from it?

Authors:  Carla E M Hollak
Journal:  Blood Cells Mol Dis       Date:  2010-06-01       Impact factor: 3.039

2.  Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease.

Authors:  D Elstein; G M Cohn; N Wang; M Djordjevic; C Brutaru; A Zimran
Journal:  Blood Cells Mol Dis       Date:  2010-08-19       Impact factor: 3.039

3.  Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience.

Authors:  Ari Zimran; Gheona Altarescu; Mici Philips; Drorit Attias; Marina Jmoudiak; Maher Deeb; Nan Wang; Kiran Bhirangi; Gabriel M Cohn; Deborah Elstein
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

4.  A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

Authors:  Elena Lukina; Nora Watman; Elsa Avila Arreguin; Maryam Banikazemi; Marta Dragosky; Marcelo Iastrebner; Hanna Rosenbaum; Mici Phillips; Gregory M Pastores; Daniel I Rosenthal; Mathilde Kaper; Tejdip Singh; Ana Cristina Puga; Peter L Bonate; M Judith Peterschmitt
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

5.  Replacement therapy with imiglucerase for type 1 Gaucher's disease.

Authors:  A Zimran; D Elstein; E Levy-Lahad; S Zevin; I Hadas-Halpern; Y Bar-Ziv; J Foldes; A J Schwartz; A Abrahamov
Journal:  Lancet       Date:  1995-06-10       Impact factor: 79.321

6.  Monitoring of Gaucher patients with a novel chitotriosidase assay.

Authors:  Aricha Schoonhoven; Bernard Rudensky; Debbie Elstein; Ari Zimran; Carla E M Hollak; Johanna E Groener; Johannes M F G Aerts
Journal:  Clin Chim Acta       Date:  2007-03-06       Impact factor: 3.786

7.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Authors:  N W Barton; R O Brady; J M Dambrosia; A M Di Bisceglie; S H Doppelt; S C Hill; H J Mankin; G J Murray; R I Parker; C E Argoff
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

8.  Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.

Authors:  You-Hai Xu; Ying Sun; Sonya Barnes; Gregory A Grabowski
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 9.  Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Authors:  T M Cox; J M F G Aerts; N Belmatoug; M D Cappellini; S vom Dahl; J Goldblatt; G A Grabowski; C E M Hollak; P Hwu; M Maas; A M Martins; P K Mistry; G M Pastores; A Tylki-Szymanska; J Yee; N Weinreb
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982

10.  A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation.

Authors:  David Aviezer; Einat Brill-Almon; Yoseph Shaaltiel; Sharon Hashmueli; Daniel Bartfeld; Sarah Mizrachi; Yael Liberman; Arnold Freeman; Ari Zimran; Eithan Galun
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240
View more
  9 in total

1.  Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.

Authors:  Nick Dekker; Laura van Dussen; Carla E M Hollak; Herman Overkleeft; Saskia Scheij; Karen Ghauharali; Mariëlle J van Breemen; Maria J Ferraz; Johanna E M Groener; Mario Maas; Frits A Wijburg; Dave Speijer; Anna Tylki-Szymanska; Pramod K Mistry; Rolf G Boot; Johannes M Aerts
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

2.  Direct site-specific glycoform identification and quantitative comparison of glycoprotein therapeutics: imiglucerase and velaglucerase alfa.

Authors:  Hongping Ye; John Hill; Ashley C Gucinski; Michael T Boyne; Lucinda F Buhse
Journal:  AAPS J       Date:  2014-12-13       Impact factor: 4.009

3.  Gaucher disease and cancer: concept and controversy.

Authors:  Francis Y M Choy; Tessa N Campbell
Journal:  Int J Cell Biol       Date:  2011-06-07

Review 4.  Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.

Authors:  Johannes M F G Aerts; Wouter W Kallemeijn; Wouter Wegdam; Maria Joao Ferraz; Marielle J van Breemen; Nick Dekker; Gertjan Kramer; Ben J Poorthuis; Johanna E M Groener; Josanne Cox-Brinkman; Saskia M Rombach; Carla E M Hollak; Gabor E Linthorst; Martin D Witte; Henrik Gold; Gijs A van der Marel; Herman S Overkleeft; Rolf G Boot
Journal:  J Inherit Metab Dis       Date:  2011-03-29       Impact factor: 4.982

Review 5.  Gaucher disease and the synucleinopathies: refining the relationship.

Authors:  Tessa N Campbell; Francis Y M Choy
Journal:  Orphanet J Rare Dis       Date:  2012-01-31       Impact factor: 4.123

6.  Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.

Authors:  Wouter W Kallemeijn; Saskia Scheij; Sascha Hoogendoorn; Martin D Witte; Daniela Herrera Moro Chao; Cindy P A A van Roomen; Roelof Ottenhoff; Herman S Overkleeft; Rolf G Boot; Johannes M F G Aerts
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

Review 7.  Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.

Authors:  Elena Seranova; Kyle J Connolly; Malgorzata Zatyka; Tatiana R Rosenstock; Timothy Barrett; Richard I Tuxworth; Sovan Sarkar
Journal:  Essays Biochem       Date:  2017-12-12       Impact factor: 8.000

8.  Generation of a Chinese hamster ovary cell line producing recombinant human glucocerebrosidase.

Authors:  Juliana Branco Novo; Ligia Morganti; Ana Maria Moro; Adriana Franco Paes Leme; Solange Maria de Toledo Serrano; Isaias Raw; Paulo Lee Ho
Journal:  J Biomed Biotechnol       Date:  2012-10-03

9.  Endosperm-specific expression of human acid beta-glucosidase in a waxy rice.

Authors:  Tamara Patti; Bruno Bembi; Piero Cristin; Flavia Mazzarol; Erika Secco; Carla Pappalardo; Rita Musetti; Maurizio Martinuzzi; Serena Versolatto; Roberta Cariati; Andrea Dardis; Stefano Marchetti
Journal:  Rice (N Y)       Date:  2012-12-06       Impact factor: 4.783
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.